80 results
Page 2 of 4
8-K
EX-99.1
npug4nw
5 Oct 23
Longeveron Announces Positive Top-Line Results for Lomecel-BTM in its CLEAR MIND Phase 2a Clinical Trial in the Treatment of Mild Alzheimer’s Disease
7:36am
424B3
q2xawneop2sd9705a
14 Aug 23
Prospectus supplement
4:45pm
8-K
EX-99.1
xgykjzl6o h2n8j05x
23 Jun 23
Regulation FD Disclosure
8:00am
DEF 14A
zxyiy y6ck
13 May 22
Definitive proxy
4:10pm
8-K
EX-99.1
6owketc6a af1j8
13 May 22
Longeveron Inc. Provides Corporate Update and Reports First Quarter 2022 Financial Results
9:50am
8-K
EX-99.1
dejylym4lo8iunroa8
9 May 22
Longeveron Announces CEO Transition
4:26pm
S-3
xctieh3
5 Apr 22
Shelf registration
4:28pm
8-K
EX-99.1
byfis56y 2cznbdzw
5 Apr 22
Longeveron Expands Executive Leadership Team; Appoints
4:01pm
8-K
EX-10.1
lekstrpap7ishr 3yo
5 Apr 22
Longeveron Expands Executive Leadership Team; Appoints
4:01pm
8-K
EX-99.1
uhtx7r7jo
11 Mar 22
Longeveron Announces Fourth Quarter and Full Year 2021 Financial Results and Operational Progress
8:45am